Skip to main content

Ceres signs license agreement

Ceres Inc. (Nasdaq: CERE) licensed its Persephone bioinformatics technology to KWS SAST SE sending the stock price soaring 27 cents to close at $1.28.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.